Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.
Saved in:
| Title: | Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial. |
|---|---|
| Authors: | Jochum F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Dumas É; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Institute of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Salem JE; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France., Ederhy S; Cardiology Department, Saint-Antoine University Hospital, AP-HP, Paris, France., Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France., Lecointre L; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Laas E; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France., Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France.; Department of Surgical Oncology, Institut Godinot, Reims, France., Lecuru F; Department of Breast and Gynaecological Surgery, Institut Curie, Paris, France., Akladios C; Department of Gynaecology, Strasbourg University Hospital, Strasbourg, France., Gougis P; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.; Clinical Investigation Center (CIC-1901) INSERM, Department of Pharmacology, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.; Department of Medical Oncology, Sorbonne Université, Institut Universitaire du Cancer, Pitié-Salpêtrière Hospital, Paris, France. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Jan; Vol. 119 (1), pp. 198-207. Date of Electronic Publication: 2025 Sep 26. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
